Farmanews.com

Notas de Prensa  

Farmacéuticas. 19 de octubre de 2017
Sta pharmaceutical

STA Pharmaceutical to open new transition metal catalysis center in Changzhou, China

The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform.

STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated API process R&D and manufacturing site in Changzhou China. The new state-of-the-art facility will allow STA to carry out rapid screening of metal catalysts, ligands, bases, acids, chemical resolving reagents, and amide formation coupling reagents, etc. The screening kits will enable high-throughput screening of metal catalysts and ligands for C-C, C-N, C-O and C-S formation reactions, as well as many other types of reactions such as chemical resolution and amide formation. The technology allows the STA team to more rapidly find the optimal catalysts using a parallel interactive testing approach.

A team of scientists specialized in this technology are currently being trained in the company’s Shanghai R&D center, and, once the new center becomes fully operational in early November, will move to the Changzhou site.



Media Contacts // De Facto Communications:

Alex Heeley or Alex Allsop

T: +44 (0) 203 735 8168

E: a.heeley@defacto.com / a.allsop@defacto.com

 

Subir  

Subir notas de prensa y convocatorias

Próximas convocatorias   

  • Día Mundial del Ictus
  • Fecha: 27 de noviembre de 2017
  • Lugar: Instituto de la Mujer y para la Igualdad de Oportunidades C/ Condesa de Venadito, 34. Madrid

Ver todas

Especialidades  

Busca notas de prensa por especialidad médica o enfermedad.



Ver todas

Archivo  

Busca notas de prensa por su fecha de edición.

  Selecciona el año


Copyright © 2017, Farmavet, S.L. Todos los derechos reservados.